Author:
NICHOLSON R. I.,HUTCHESON I. R.,HARPER M. E.,KNOWLDEN J. M.,BARROW D.,McCLELLAND R. A.,JONES H. E.,WAKELING A. E.,GEE J.M. W.
Subject
History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience
Reference75 articles.
1. In
2. New anti-hormonal approaches to breast cancer therapy;Nicholson;Drugs of Today,1993
3. Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer;Nicholson;Br. J. Cancer,2000
4. Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity;Freiss;Biochem. Biophys. Res. Commun.,1990
5. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-1R) signalling pathway in breast cancer cells;Guvakova;Cancer Res.,1997